Suggested Searches

photo of Andrew J Hart
502-897-1166

Andrew J Hart, MD

Hematology Oncology
Gender: Male
4.9 of 5 (111 Ratings)
Accepting New Patients
Virtual Visits

Practice Locations

A:
Baptist Health Medical Group Hematology & Oncology
4003 Kresge Way, Suite 500
Louisville, KY 40207
502-897-1166 502-897-1461
B:
Baptist Health Medical Group Hematology & Oncology
2400 Eastpoint Parkway, Suite 310
Louisville, KY 40223
502-897-1166 502-897-1461
C:
Baptist Health Louisville Multi-Disciplinary Clinic
4003 Kresge Way
Louisville, KY 40207
502-896-3009 502-259-4097
D:
Baptist Health Medical Group Hematology & Oncology
1031 New Moody Lane, Suite 204
La Grange, KY 40031
502-897-1166 502-897-1461

Education

Medical School

Indiana University School of Medicine

Internship

Vanderbilt University School of Medicine

Residency

Vanderbilt University School of Medicine

Fellowship

Vanderbilt University School of Medicine

Fellowship

Vanderbilt University School of Medicine

Board Certifications

Medical Oncology

American Board of Internal Medicine

Hematology

American Board of Internal Medicine

Hospital Affiliations

  • Baptist Health LaGrange
  • Baptist Health Louisville

Philosophy of Care

Baptist Health Medical Group is a comprehensive, multispecialty network of physicians and advanced practice clinicians. Our providers are committed to providing compassionate, patient-centered care and strive to treat our patients the way we would want to be treated, every time, at every Baptist Health location.

Reviews

Patient Experience Ratings

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Overall Rating
4.9 out of 5 (111 Ratings)
Review Categories
Patient Comments

Research

  • Bladder Urothelial Carcinoma; Stage III Bladder Cancer AJCC v8; Stage IIIA Bladder Cancer AJCC v8; Stage IIIB Bladder Cancer AJCC v8

    EA8185: Phase II Study of Bladder-SparIng ChemoradiatioN with MEDI4736 (Durvalumab) in Clinical Stage III, Node PosItive BladdeR CancEr (INSPIRE)

    Trial Details
  • Bladder Urothelial Carcinoma<br> Muscle Invasive Bladder Carcinoma <br>Stage II Bladder Cancer AJCC v8 <br>Stage III Bladder Cancer AJCC v8 <br>Stage IIIA Bladder Cancer AJCC v8

    S1806: Phase III Randomized Trial of Concurrent Chemoradiotherapy with or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer

    Trial Details

About Andrew J Hart

Featured HealthTalks